Notably, CD8T_GNLY+ in tumor samples were also enriched in multiple resistance pathways, including the EGFR tyrosine kinase inhibitor resistance pathway, suggesting that the immunosuppressive microenvironment is promoting or maintaining EGFR-TKI resistance (Figure 3E). The gene discussed is EGFR; the disease is neoplasm.